狂犬病疫苗市场报告：2030 年趋势、预测与竞争分析

狂犬病疫苗趋势与预测

预计到 2030 年，全球狂犬病疫苗市场将达到 12 亿美元，2024 年至 2030 年复合年增长率为 4.4%。该市场的主要驱动力是提高人们对狂犬病风险的认识，并配合措施控制狐狸和浣熊等野生动物族群的狂犬病。由于医院、居家医疗和专科诊所市场的机会，全球狂犬病疫苗市场前景看好。

狂犬病疫苗市场洞察

Lucintel 预测，Vero 细胞由于其许多优点，包括可行性、安全性、高免疫抗原性以及可用于暴露前和暴露后预防的能力，预计在预测期内增长最快。

由于医院狂犬病疫苗处方笺呈增加趋势，预计该市场在预测期内将出现最高增长。

由于其强大的医疗基础设施和不断增长的製药公司数量，预计北美仍将是最大的地区。

市场规模/估计：以金额估计狂犬病疫苗的市场规模（10 亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

細項分析：按产品类型、疫苗接种类型、应用、最终用途和地区等各个细分市场估计狂犬病疫苗市场金额（以美元计）。

区域分析：北美、欧洲、亚太地区和世界其他地区的狂犬病疫苗市场区隔。

成长机会：按产品类型、疫苗类型、应用、最终用途和地区对狂犬病疫苗市场进行成长机会分析。

策略分析：狂犬病疫苗市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

• Q.1. 细分市场中最有前途和高成长的机会是什么？
• Q.2.哪个细分市场将以更快的速度成长？为什么？
• Q.3.您认为哪些地区未来会出现更快的成长？为什么？
• Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
• Q.5. 这个市场的商业风险和竞争威胁是什么？
• Q.6.这个市场有哪些新趋势？为什么？
• Q.7.市场客户需求有何改变？
• Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
• Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
• Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
• Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球狂犬病疫苗市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球狂犬病疫苗市场趋势（2018-2023）与预测（2024-2030）
• 按产品类型分類的全球狂犬病疫苗市场
  • 仓鼠宝宝肾
  • 精製鸡胚细胞狂犬病疫苗
  • Vero细胞狂犬病疫苗
  • 其他的
• 按疫苗类型分類的全球狂犬病疫苗市场
  • 暴露前疫苗接种 (PEV)
  • 暴露后预防 (PEP)
• 全球狂犬病疫苗市场按应用
  • 动物
  • 人类
• 全球狂犬病疫苗市场（依最终用途）
  • 医院
  • 居家护理
  • 专科诊所
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 全球狂犬病疫苗市场区域分布
• 北美狂犬病疫苗市场
• 欧洲狂犬病疫苗市场
• 亚太地区狂犬病疫苗市场
• 其他地区狂犬病疫苗市场

第五章竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 按产品类型分類的全球狂犬病疫苗市场成长机会
  • 按疫苗类型分類的全球狂犬病疫苗市场成长机会
  • 全球狂犬病疫苗市场成长机会（按应用）
  • 全球狂犬病疫苗市场成长机会（依最终用途）
  • 全球狂犬病疫苗市场成长机会（按地区）
• 全球狂犬病疫苗市场新趋势
• 战略分析
  • 新产品开发
  • 全球狂犬病疫苗市场产能扩张
  • 全球狂犬病疫苗市场的合併、收购与合资企业
  • 认证和许可

第七章主要企业概况

• Serum Institute of India
• Novartis
• Cadila Pharmaceuticals
• Merck
• Sanofi
• ADS Diagnostic
• GSK

Rabies Vaccine Trends and Forecast

The future of the global rabies vaccine market looks promising with opportunities in the hospital, homecare, and specialty clinic markets. The global rabies vaccine market is expected to reach an estimated $1.2 billion by 2030 with a CAGR of 4.4% from 2024 to 2030. The major drivers for this market are rising awareness about the risks of rabies and growing efforts to control rabies in wildlife populations, such as foxes and raccoons.

A more than 150-page report is developed to help in your business decisions.

Rabies Vaccine by Segment

The study includes a forecast for the global rabies vaccine by product type, vaccination type, application, end use, and region.

Rabies Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Baby Hamster Kidney
• Purified Chick Embryo Cell Rabies Vaccine
• Vero Cell Rabies Vaccine
• Others

Rabies Vaccine Market by Vaccination Type [Shipment Analysis by Value from 2018 to 2030]:

• Pre-Exposure Vaccination (PEV)
• Post-Exposure Prophylaxis (PEP)

Rabies Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Animal
• Human

Rabies Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Homecare
• Specialty Clinics
• Others

Rabies Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Rabies Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rabies vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rabies vaccine companies profiled in this report include-

• Serum Institute of India
• Novartis
• Cadila Pharmaceuticals
• Merck
• Sanofi
• ADS Diagnostic
• GSK

Rabies Vaccine Market Insights

Lucintel forecasts that vero cell is expected to witness highest growth over the forecast period due to its numerous benefits, such as its feasibility, safety, high immunogenicity, and can be used for pre- and post-exposure prophylaxis.

Within this market, hospital is expected to witness highest growth over the forecast period due to increasing rabies vaccination prescriptions tend to be issued within this facility.

North America will remain the largest region due to existence of robust healthcare infrastructure and expanding number of pharmaceutical companies in the region.

Features of the Global Rabies Vaccine Market

Market Size Estimates: Rabies vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rabies vaccine market size by various segments, such as by product type, vaccination type, application, end use, and region in terms of ($B).

Regional Analysis: Rabies vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, vaccination types, applications, end uses, and regions for the rabies vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rabies vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rabies vaccine market size?

Answer: The global rabies vaccine market is expected to reach an estimated $1.2 billion by 2030.

Q.2 What is the growth forecast for rabies vaccine market?

Answer: The global rabies vaccine market is expected to grow with a CAGR of 4.4% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rabies vaccine market?

Answer: The major drivers for this market are rising awareness about the risks of rabies and growing efforts to control rabies in wildlife populations, such as foxes and raccoons.

Q4. What are the major segments for rabies vaccine market?

Answer: The future of the rabies vaccine market looks promising with opportunities in the hospital, homecare, and specialty clinic markets.

Q5. Who are the key rabies vaccine market companies?

Answer: Some of the key rabies vaccine companies are as follows:

• Serum Institute of India
• Novartis
• Cadila Pharmaceuticals
• Merck
• Sanofi
• ADS Diagnostic
• GSK

Q6. Which rabies vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that vero cell is expected to witness highest growth over the forecast period due to its numerous benefits, such as its feasibility, safety, high immunogenicity, and can be used for pre- and post-exposure prophylaxis.

Q7. In rabies vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure and expanding number of pharmaceutical companies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the rabies vaccine market by product type (baby hamster kidney, purified chick embryo cell rabies vaccine, vero cell rabies vaccine, and others), vaccination type (pre-exposure vaccination (PEV) and post-exposure prophylaxis (PEP)), application (animal and human), end use (hospitals, homecare, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rabies Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Rabies Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Rabies Vaccine Market by Product Type
  • 3.3.1: Baby Hamster Kidney
  • 3.3.2: Purified Chick Embryo Cell Rabies Vaccine
  • 3.3.3: Vero Cell Rabies Vaccine
  • 3.3.4: Others
• 3.4: Global Rabies Vaccine Market by Vaccination Type
  • 3.4.1: Pre-Exposure Vaccination (PEV)
  • 3.4.2: Post-Exposure Prophylaxis (PEP)
• 3.5: Global Rabies Vaccine Market by Application
  • 3.5.1: Animal
  • 3.5.2: Human
• 3.6: Global Rabies Vaccine Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Homecare
  • 3.6.3: Specialty Clinics
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Rabies Vaccine Market by Region
• 4.2: North American Rabies Vaccine Market
  • 4.2.2: North American Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.3: European Rabies Vaccine Market
  • 4.3.1: European Rabies Vaccine Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.3.2: European Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.4: APAC Rabies Vaccine Market
  • 4.4.1: APAC Rabies Vaccine Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.4.2: APAC Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.5: ROW Rabies Vaccine Market
  • 4.5.1: ROW Rabies Vaccine Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.5.2: ROW Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Rabies Vaccine Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Rabies Vaccine Market by Vaccination Type
  • 6.1.3: Growth Opportunities for the Global Rabies Vaccine Market by Application
  • 6.1.4: Growth Opportunities for the Global Rabies Vaccine Market by End Use
  • 6.1.5: Growth Opportunities for the Global Rabies Vaccine Market by Region
• 6.2: Emerging Trends in the Global Rabies Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Rabies Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rabies Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Serum Institute of India
• 7.2: Novartis
• 7.3: Cadila Pharmaceuticals
• 7.4: Merck
• 7.5: Sanofi
• 7.6: ADS Diagnostic
• 7.7: GSK